Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry+publication

Gabapentin tinnitus study cluster

Also known as: Gabapentin, Neurontin, Gabapentin tinnitus trial, NCT00257270, NCT00555776

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Small Molecule

Stage

Phase 2

Status

Completed

Target Gene

—

Route / Mode

Oral tablet/capsule

Confidence

86%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

United States, Iran

Population

adult, tinnitus, noise-induced, repurposed-drug

Trial IDs

Mechanism

Historical Phase 2 clinical-study cluster evaluating oral gabapentin for chronic or idiopathic subjective tinnitus, including a completed Tinnitus Research Consortium study and an Islamic Azad University placebo-controlled pilot study.

Indications

Tinnitus Noise-Induced Hearing Loss

Notes

Corrected from a generic drug row to a historical tinnitus study cluster. The two linked Phase 2 studies are academic/nonprofit, not a current commercial gabapentin tinnitus program. NCT00555776 has a linked publication; NCT00257270 is completed with registry-reported study details.

Evidence & Sources

3 structured sources

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT00257270

Open

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT00555776

Open

publication

Supports: status, mechanism, notes, keyEvents